Literature DB >> 16283214

Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review.

D C B Lye1, A Hughes, D O'Brien, E Athan.   

Abstract

Reported here is the case of a 72-year-old man who was diagnosed with Candida glabrata prosthetic mitral valve endocarditis and treated successfully with fluconazole plus caspofungin after he refused and was determined unfit for surgery. Initial treatment with intravenous amphotericin B resulted in acute renal impairment. Despite 8 days of intravenous fluconazole therapy, he remained fungemic. Caspofungin was added to the treatment regimen with subsequent sterilisation of blood culture. The patient was treated for 34 days with caspofungin and 41 days with fluconazole. He continued oral fluconazole after hospital discharge and remained well at follow-up 11 months later. The role of fluconazole and caspofungin in the treatment of Candida endocarditis is discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16283214     DOI: 10.1007/s10096-005-0038-2

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  20 in total

1.  Guidelines for treatment of candidiasis.

Authors:  Peter G Pappas; John H Rex; Jack D Sobel; Scott G Filler; William E Dismukes; Thomas J Walsh; John E Edwards
Journal:  Clin Infect Dis       Date:  2003-12-19       Impact factor: 9.079

2.  Caspofungin for Candida endocarditis.

Authors:  Wojciech Mrówczyński; Michal Wojtalik
Journal:  Pediatr Infect Dis J       Date:  2004-04       Impact factor: 2.129

Review 3.  Antifungal agents: in vitro susceptibility testing, pharmacodynamics, and prospects for combination therapy.

Authors:  A H Groll; H Kolve
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-11       Impact factor: 3.267

4.  Failure of caspofungin to treat brain abscesses secondary to Candida albicans prosthetic valve endocarditis.

Authors:  Rajesh M Prabhu; Robert Orenstein
Journal:  Clin Infect Dis       Date:  2004-10-15       Impact factor: 9.079

Review 5.  Candida prosthetic valve endocarditis: prospective study of six cases and review of the literature.

Authors:  M H Nguyen; M L Nguyen; V L Yu; D McMahon; T F Keys; M Amidi
Journal:  Clin Infect Dis       Date:  1996-02       Impact factor: 9.079

6.  Long-term survival after fluconazole therapy of candidal prosthetic valve endocarditis.

Authors:  Frank S Czerwiec; Martin S Bilsker; Max L Kamerman; Alan L Bisno
Journal:  Am J Med       Date:  1993-05       Impact factor: 4.965

7.  In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies.

Authors:  Gordon Ramage; Kacy VandeWalle; Stefano P Bachmann; Brian L Wickes; José L López-Ribot
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

Review 8.  Fungal endocarditis: evidence in the world literature, 1965-1995.

Authors:  M E Ellis; H Al-Abdely; A Sandridge; W Greer; W Ventura
Journal:  Clin Infect Dis       Date:  2000-12-12       Impact factor: 9.079

9.  Surgical and long-term antifungal therapy for fungal prosthetic valve endocarditis.

Authors:  D D Muehrcke; B W Lytle; D M Cosgrove
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

Review 10.  Status of combination therapy for refractory mycoses.

Authors:  Anastasia Antoniadou; Dimitrios P Kontoyiannis
Journal:  Curr Opin Infect Dis       Date:  2003-12       Impact factor: 4.915

View more
  12 in total

1.  Conservative management of Candida infection of prosthetic aortic graft by means of caspofungin and fluconazole alone.

Authors:  Lukas J Motloch; Dennis Rottlaender; Turak Darabi; Insa Joost; Erland Erdmann; Uta C Hoppe
Journal:  Tex Heart Inst J       Date:  2011

2.  Candida infective endocarditis: an observational cohort study with a focus on therapy.

Authors:  Christopher J Arnold; Melissa Johnson; Arnold S Bayer; Suzanne Bradley; Efthymia Giannitsioti; José M Miró; Pilar Tornos; Pierre Tattevin; Jacob Strahilevitz; Denis Spelman; Eugene Athan; Francisco Nacinovich; Claudio Q Fortes; Cristiane Lamas; Bruno Barsic; Nuria Fernández-Hidalgo; Patricia Muñoz; Vivian H Chu
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

3.  Fungal endocarditis.

Authors:  George M Varghese; Jack D Sobel
Journal:  Curr Infect Dis Rep       Date:  2008-07       Impact factor: 3.725

Review 4.  Infective endocarditis.

Authors:  Yok-Ai Que; Philippe Moreillon
Journal:  Nat Rev Cardiol       Date:  2011-04-12       Impact factor: 32.419

5.  Candida infective endocarditis.

Authors:  J W Baddley; D K Benjamin; M Patel; J Miró; E Athan; B Barsic; E Bouza; L Clara; T Elliott; Z Kanafani; J Klein; S Lerakis; D Levine; D Spelman; E Rubinstein; P Tornos; A J Morris; P Pappas; V G Fowler; V H Chu; C Cabell
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-02-19       Impact factor: 3.267

6.  Surgery for infective endocarditis.

Authors:  Patricia D Brown
Journal:  Curr Infect Dis Rep       Date:  2007-07       Impact factor: 3.725

7.  Fungal endocarditis of a bioprosthetic aortic valve. Pharmacological treatment of a Candida parapsilosis endocarditis.

Authors:  M Wallner; G Steyer; R Krause; C Gstettner; D von Lewinski
Journal:  Herz       Date:  2012-12-23       Impact factor: 1.443

8.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David R Andes; Cornelius J Clancy; Kieren A Marr; Luis Ostrosky-Zeichner; Annette C Reboli; Mindy G Schuster; Jose A Vazquez; Thomas J Walsh; Theoklis E Zaoutis; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2015-12-16       Impact factor: 9.079

9.  Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David Andes; Daniel K Benjamin; Thierry F Calandra; John E Edwards; Scott G Filler; John F Fisher; Bart-Jan Kullberg; Luis Ostrosky-Zeichner; Annette C Reboli; John H Rex; Thomas J Walsh; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2009-03-01       Impact factor: 9.079

10.  Successful treatment of Candida parapsilosis mural endocarditis with combined caspofungin and voriconazole.

Authors:  Víctor López-Ciudad; María J Castro-Orjales; Cristóbal León; César Sanz-Rodríguez; María J de la Torre-Fernández; Miguel A Pérez de Juan-Romero; María D Collell-Llach; María D Díaz-López
Journal:  BMC Infect Dis       Date:  2006-04-11       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.